A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD-Reference-Cited by-同舟云学术

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD

Published:2016-11 Issue: Volume:120 Page:16-24
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Tashkin Donald P.,Martinez Fernando J.,Rodriguez-Roisin Roberto,Fogarty Charles,Gotfried Mark,Denenberg Michael,Gottschlich Gregory,Donohue James F.,Orevillo Chad,Darken Patrick,St Rose Earl,Strom Shannon,Fischer Tracy,Golden Michael,Reisner Colin

Funder

Pearl Therapeutics Inc.

Catherine Stanton, Complete Medical Communications, Macclesfield, UK

AstraZeneca. Everest Clinical Research Services, Ontario, Canada

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference46 articles.

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Diseases (GOLD);Global Initiative for Chronic Obstructive Lung Disease,2016

2. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function;Cazzola;COPD,2009

3. Pharmacology and therapeutics of bronchodilators;Cazzola;Pharmacol. Rev.,2012

4. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease;Tashkin;Respir. Res.,2013

5. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study;Bateman;Eur. Respir. J.,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

;International Journal of Chronic Obstructive Pulmonary Disease;2020-11

2. Glycopyrrolate and formoterol fumarate for the treatment of COPD;Expert Review of Respiratory Medicine;2020-10-12

3. Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD;Therapeutic Advances in Respiratory Disease;2020-01

4. Glycopyrronium/Formoterol: A Review in COPD;Drugs;2019-08-29

5. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2019-03-06